Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide plus dexamethasone versus observation in high-risk smoldering multiple myeloma
2007-000649-36Phase 3Terminated
- Sponsor
- Fundación PETHEMA
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in smoldering multiple myeloma (SMM) comparing Revlimid + dexamethasone with Observation (2 arms). Started Apr 2007; status: terminated.
02
Drugs
lenalidomidedexamethasone
03
Conditions
smoldering multiple myeloma (SMM)
Beyond the preview
Go deeper on 2007-000649-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000649-36.